Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14441612 | 0.92 | KDM4E (0.31) | KDM4EMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL1906786 | 0.85 | — | — | |
| SCHEMBL649183 | 0.82 | — | — | |
| SCHEMBL20993021 | 0.75 | KDM4E (0.40) | KDM4EMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL14938098 | 0.67 | KDM4E (0.33) | KDM4EMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL457571 | 0.67 | KDM4E (0.31) | KDM4EMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL22939433 | 0.67 | LMNA (0.36) | — | |
| SCHEMBL2141088 | 0.64 | — | — | |
| SCHEMBL8750864 | 0.64 | — | — | |
| SCHEMBL6081753 | 0.63 | MEN1 (0.55) | KDM4EMEN1ALDH1A1MAPTALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6868215-B2 | Dye thin film, production method thereof, optical switch, optical distributor, optical modulator and optical switch array | FUJI XEROX CO., LTD. (JP) | 2005-03-15 | — | — | US | disclosed |
| US-6825363-B2 | A DIBENZOFURANONYLIUM METHYLATE DERIVATIVES ZWITTERIONS, OBTAINED FROM A CYCLIZATION REACTION; MAXIMUM ABSORPTION WAVELENGTH, THERMAL STABILITY AND GOOD SOLUBILITY IN SOLVENTS | FUJI XEROX CO., LTD. (JP) | 2004-11-30 | — | — | US | disclosed |
| US-20040001666-A1 | Dye thin film, production method thereof, optical switch, optical distributor, optical modulator and optical switch array | FUJI XEROX CO., LTD. (JP) | 2004-01-01 | — | — | US | disclosed |
| US-20030220511-A1 | Novel compounds useful, for example, in optical switching and manufacturing method thereof | FUJI XEROX CO., LTD. (JP) | 2003-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220511-A1 | Novel compounds useful, for example, in optical switching and manufacturing method thereof | CYP51A1, MALT1, MGMT | KDM4E 609/4885MEN1 289/4885ALDH1A1 939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.